NCT00591084View on ClinicalTrials.gov

Ginsenoside-Rd for Acute Ischemic Stroke

PHASE2CompletedINTERVENTIONAL
Enrollment

199

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

June 30, 2006

Study Completion Date

September 30, 2006

Conditions
Ischemic Stroke
Interventions
DRUG

ginsenoside-Rd 10 mg

infusion ginsenoside-Rd 10 mg (group A)once a day and continued for 14 days

DRUG

placebo

infusion placebo (group B)once a day and continued for 14 days

DRUG

ginsenoside-Rd 20mg

infusion of ginsenoside-Rd 20mg (group C) once a day and continued for 14 days

Trial Locations (1)

710032

the Department of Neurology , Xijing Hospital, Xi'an

All Listed Sponsors
lead

Xijing Hospital

OTHER

NCT00591084 - Ginsenoside-Rd for Acute Ischemic Stroke | Biotech Hunter | Biotech Hunter